1. Home
  2. WVE vs HP Comparison

WVE vs HP Comparison

Compare WVE & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$15.74

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Helmerich & Payne Inc.

HP

Helmerich & Payne Inc.

HOLD

Current Price

$30.12

Market Cap

2.9B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
HP
Founded
2012
1920
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.9B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
HP
Price
$15.74
$30.12
Analyst Decision
Strong Buy
Hold
Analyst Count
16
11
Target Price
$29.94
$29.09
AVG Volume (30 Days)
13.7M
1.3M
Earning Date
11-10-2025
02-04-2026
Dividend Yield
N/A
3.34%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,230,000.00
$3,746,013,000.00
Revenue This Year
N/A
$9.18
Revenue Next Year
$16.00
$3.91
P/E Ratio
N/A
N/A
Revenue Growth
103.75
35.89
52 Week Low
$5.28
$14.65
52 Week High
$21.73
$37.30

Technical Indicators

Market Signals
Indicator
WVE
HP
Relative Strength Index (RSI) 55.08 62.59
Support Level $15.23 $27.54
Resistance Level $18.50 $29.23
Average True Range (ATR) 1.18 1.00
MACD -0.34 -0.00
Stochastic Oscillator 16.51 87.38

Price Performance

Historical Comparison
WVE
HP

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.

Share on Social Networks: